0 followers
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.
Calico
6 followers
Qualigen Therapeutics
3 followers
Vera Therapeutics
2 followers
Cargo
1 follower
Capricor Therapeutics
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Explore companies